According to Borniger et al., in a single nonmetastatic model of breast cancer, the underlying mechanism mediating cancer-associated metabolic changes and sleep disruption may be aberrant activity of wake-stabilizing hypocretin/orexin (HO) neuron (31). Here, HCRT is linked to breast carcinoma.